D
Diabeasy / Sponsor
A Caresoft programme
AM
CARE+
SPONSOR
Patient Support Programme · Active

Novo Care+ — Ryzodeg & Tresiba franchise

Sponsor ID
PSP-NN-2026-04
Programme term
Apr '26 — Mar '27
Contract value
₹ 4.2 Cr
Data refresh
12 May, 02:14 IST
Atlas / Sponsor Portal / Novo Care+ Dashboard
Programme Command

Sponsor Dashboard

Live programme telemetry across enrolment, engagement, adherence and outcomes — sourced from {{1,247}} prescribing physicians and {{38,420}} enrolled patients.

● LIVE TELEMETRY AUDIT-READY
Patients Enrolled
38,420
▲ 1,247 vs. last 30 days
Active & Engaged
31,084 / 80.9%
▲ 2.4 pp 90-day engagement
12-Mo Persistence
67.2%
▲ 8.1 pp vs. unsupported cohort
Open AE Reports
3 / 0 severe
avg 6h to triage within SLA

Enrolment Funnel · April–May 2026

Doctor-initiated enrolment outperforms call-centre acquisition by 3.2×
60-day window
Doctor-flagged eligibleFrom in-consult PSP prompt
8,940
8,940
100%
Patient consentedDPDP layered consent captured
7,241
7,241
81.0%
eKYC & activationAadhaar / DigiLocker verified
6,524
6,524
73.0%
First refill completedThrough programme pharmacy
5,720
5,720
64.0%
Retained at day 90≥2 refills, active app usage
5,185
5,185
58.0%

Geographic distribution

Enrolled patients by state
8.4K Maharashtra 5.8K Karnataka 6.2K Tamil Nadu 4.9K Delhi NCR 4.1K Gujarat 3.6K 2.9K W. Bengal 2.4K
> 6K patients 2K – 6K < 2K

Clinical Outcomes Preview · 12-month cohort

Patients enrolled before May 2025, with paired baseline and follow-up HbA1c (n = 8,142)
Mean HbA1c reduction
9.47.8%
Δ −1.6 percentage points
Patients at HbA1c < 7%
42%
vs. 14% at baseline
Avg adherence (MPR)
0.79
vs. 0.41 unsupported
Therapy discontinuation
11.8%
vs. 38% industry mean

HbA1c trajectory · enrolled vs. control

Monthly mean, matched cohorts
10.0% 9.0% 8.0% 7.0% 6.0% ADA target zone (< 7%) 7.8% mean May '26 cohort Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May '26
Care+ enrolled (n=8,142) Matched control (unsupported, n=8,142) ADA target zone

Programme activity

Last 24 hours
1,247 new enrolments across 184 prescribing clinicians since 06:00 IST.
12 May · 02:14 IST
HbA1c outcomes report generated for medical affairs · 8,142-patient cohort.
11 May · 18:42 IST
AE reported — non-severe · hypoglycaemia, Patient #DBS-04127. Triaged within 4h, action recorded.
11 May · 15:08 IST
Pharmacy refill milestone: 50,000th refill processed through programme pharmacy network.
11 May · 11:23 IST
Dr. P. Krishnan (Apollo Chennai) crossed 100 enrolments — top enrolling clinician of the month.
11 May · 09:45 IST
Coach intervention success: 142 patients re-engaged after refill-lapse outreach.
10 May · 22:10 IST

Adherence cohorts · current snapshot

MPR-segmented populations across the active programme
Cohort
Distribution
Patients
Mean MPR
HbA1c
Optimally adherent
MPR ≥ 0.85
15,851
0.92
7.1%
Partially adherent
MPR 0.60 – 0.84
9,632
0.74
7.9%
At-risk lapsing
MPR 0.40 – 0.59
4,351
0.51
9.0%
Discontinued
MPR < 0.40 / no refills 60d
2,586

Top enrolling clinicians

Last 30 days · across 8 states
PK
Dr. P. Krishnan Apollo · Chennai
142
RS
Dr. R. Sharma Fortis · Gurgaon
118
VJ
Dr. V. Joshi Hinduja · Mumbai
96
AK
Dr. A. Kumar Manipal · Bengaluru
84
SM
Dr. S. Mehta Wockhardt · Mumbai
71